If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.70m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

AGM Update

21 May 2025 07:01

RNS Number : 4655J
Science Group PLC
21 May 2025
 

 

21 May 2025

 

Science Group plc

(the "Group" or "Science Group")

 

AGM Update

 

 

Further to the update on 24 April 2025, Science Group continues to perform well with revenue and profitability slightly ahead of the Board's plan for the first 4 months of the year, despite the global volatility during April. The resilient start through this period of uncertainty, provides a good foundation for the year.

 

At 30 April 2025, Science Group had gross cash of £20.9 million and net funds of £9.0 million. In addition, the Group's revolving credit facility (£30m + £10m accordion, expiring in 2030) remains undrawn.

 

In parallel, the IT system migration across the Consultancy Division has been completed ahead of schedule and all business operations are now processed via the same platform. The Defence business is an on-premises system for security reasons and all other activities are cloud-based. This successful IT implementation, integrating all the consultancy businesses to improve efficiency and resilience, is a credit to the cross-functional collaboration within the Group.

 

Science Group shareholding in Ricardo plc is 20.08%. Commentary on the Ricardo strategy, poor operating performance and ineffective governance has been set out by Science Group in statements on 17 and 31 March, 24 April and 1 May 2025. Science Group sought to engage in dialogue with Ricardo but ultimately a general meeting has had to be requisitioned and the circular to shareholders is anticipated imminently.

 

 

- Ends -

 

 

For further information:

Science Group plc

Martyn Ratcliffe, Executive Chair

Tel: +44 (0) 1223 875 200

Jon Brett, Finance Director

www.sciencegroup.com 

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Simon Bridges, Andrew Potts

Tel: +44 (0) 20 7523 8000

MHP

Reg Hoare

Tel: +44 (0) 7831 406117

 

sciencegroup@mhpgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFZGZKKGMGKZM
Date   Source Headline
25th Sep 20181:46 pmRNSForm 8.5 (EPT/RI) - Science Group PLC
25th Sep 20189:29 amRNSForm 8.3 - Science Group Plc
24th Sep 20185:02 pmPRNForm 8.3 - Science Group Plc
24th Sep 20183:37 pmRNSForm 8.3 - Science Group PLC
24th Sep 20181:50 pmRNSForm 8.3 - Science Group Plc
24th Sep 20181:18 pmRNSForm 8.3 - Science Group Plc
24th Sep 20188:10 amRNSForm 8.5 (EPT/RI) - Science Group PLC
21st Sep 20182:32 pmRNSForm 8.3 - Unicorn Asset Management
21st Sep 20187:01 amRNSFormal Sale Process as Part of Strategic Review
21st Sep 20187:00 amRNSCorporate Strategic Review
5th Sep 20187:00 amRNSTreasury shares issued
26th Jul 201812:00 pmRNSTR1: Notification of Major Interest in Shares
24th Jul 20187:00 amRNSInterim Results
18th Jul 20187:00 amRNSNotice of Interim Results
15th May 20187:00 amRNSIssue of share options & PDMR dealing
14th May 20187:00 amRNSTreasury shares issued
25th Apr 20187:00 amRNSTreasury shares issued
19th Apr 201812:00 pmRNSResult of AGM
19th Apr 20187:01 amRNSAGM Business Update and Share Buy-Back Programme
19th Apr 20187:00 amRNSNominated Advisor and Broker
29th Mar 20187:00 amRNSTreasury shares issued
26th Mar 20187:00 amRNSFreehold Property Valuations
23rd Mar 20187:00 amRNSPosting of documents to shareholders & AGM notice
23rd Mar 20187:00 amRNSTSG Consideration
20th Mar 20187:01 amRNSTransaction in Own Shares
20th Mar 20187:00 amRNSTreasury shares issued
19th Mar 20187:00 amRNSTransaction in Own Shares
16th Mar 20187:00 amRNSTransaction in Own Shares
15th Mar 20187:00 amRNSTR1: Notification of Major Interest in Shares
15th Mar 20187:00 amRNSTreasury shares issued & PDMR dealing(Replacement)
14th Mar 20187:00 amRNSTreasury shares issued & PDMR dealing
28th Feb 20187:00 amRNSAudited results for year ended 31 December 2017
22nd Feb 20183:16 pmRNSNotice of Preliminary Results
4th Jan 20187:00 amRNSTR1: Notification of Major Interest in Shares
20th Dec 20177:00 amRNSTR1: Notification of Major Interest in Shares
6th Dec 20177:00 amRNSTR1 Notification of Major Interest in Shares
18th Oct 20177:00 amRNSTreasury shares issued
21st Sep 20177:00 amRNSTR-1: Notification of Major Interest in Shares
7th Sep 20177:00 amRNSIssue of Share Options and PDMR Dealing
6th Sep 20177:00 amRNSAcquisition of Technology Sciences Group
4th Sep 20177:00 amRNSAcquisition of Technology Sciences Group
1st Aug 20172:00 pmRNSTR-1: Notification of Major Interest in Shares
31st Jul 20174:20 pmRNSTR-1: Notification of Major Interest in Shares
28th Jul 201710:40 amRNSTR-1: Notification of Major Interest in Shares
25th Jul 20177:00 amRNSInterim Results
20th Jul 20175:29 pmRNSNotice of Interim Results (Replacement)
20th Jul 20173:15 pmRNSNotice of Interim Results
18th May 201710:15 amRNSResult of AGM
15th May 20177:00 amRNSTreasury shares issued
21st Apr 20177:00 amRNSPosting of Documents and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.